Log in

Login to your account

Username
Password *
Remember Me

PAD-IQ Logo 2013

  • Supports Non-Invasive Upper and Lower Extremity Vascular Assessments
    • Skin Perfusion Pressure – Microcirculation (segmental pressure assessments with reactive hyperemia)
    • Pulse Volume Recording (segmental volume plethysmography)
    • Ankle Brachial Index (ABI) Calculation for Doppler-obtained pressures

Vasamed Supports Telemedicine

SensiLase PAD-IQ can go wherever you treat patients; a ruggedized, customized roller bag keeps the product safe and has ample room for supplies. SensiLase PAD-IQ features access to the internet via Bluetooth, WiFi or Ethernet while Studycast permits you to log-in from anywhere to upload data and images for expert consult and secure data storage.

Read More

Are you using your “IQ” to test for PAD and CLI?

Väsamed’s SensiLase PAD-IQ System featuring Studycast Data Management offers health professionals numerous support tools for both PAD and CLI to enable noninvasive vascular diagnostics, data communication and management. Read more about tissue perfusion, reactive hyperemia, volume plethysmography and wound imaging here.

Read More

19302784

Who is at risk for P.A.D?

Patients over age 50 and who also have a history of diabetes or history of smoking are at risk of PAD. Even patients under age 50 but who have diabetes and risk factors such as obesity, high blood pressure, a history of non-healing ulcers, erectile dysfunction (ED) or kidney disease (CKD/ESRD) are at risk. Consult your doctor if you exhibit these risk-factors.

Read More

Latest News

  • PAD Testing: Methods, Myths And Medicare Requirements
    Written by
    Dr. Lee Rogers authored this informative article about PAD Testing which appeared in the June 2014 issue of Podiatry Today. The article reviews the challenges associated with PAD identification and quantification in patients with diabetic ischemic disease of the toe/foot , provides guidance relative to appropriate testing and describes the…
    Written on Wednesday, 27 August 2014 19:00 in Vasamed News Read more...
  • AMP 2014
    Written by
    John Campbell and James Rice, Väsamed demonstrating PAD-IQ for CLI @AMPsymp2014 where there was intense interest in angiosome guided diagnostics to help in the fight against amputations for patients suffering from diabetes.  Many thanks to Dr. Mustapha for authoring “Advanced Tibial Pedal Access Manual” and distributing to attendees with the…
    Written on Monday, 18 August 2014 20:43 in Vasamed News
  • 2 in 5 American adults will develop diabetes
    Written by
    2 in 5 American adults will develop diabetes according to new research from the Centers for Disease Control and Prevention (CDC) and Emory University, Atlanta, Georgia, published online August 13 in Lancet Diabetes & Endocrinology. About 40% of US adults will develop diabetes, primarily type 2, in their lifetime, and over 50% of…
    Written on Thursday, 14 August 2014 17:47 in Vasamed News
  • Amputation Prevention Symposium 2014
    Written by
    Come see us at the Amputation Prevention Symposium in Chicago at the Palmer House, August 14-16, Booth 209. Please make time to check out the poster "Amputation Prevention: The Importance of Endovascular and Podiatric Surgical Partnership and Peripheral Artery Disease Awareness Among Physicians Treating Diabetes and Chronic Kidney Disease by…
    Written on Thursday, 14 August 2014 17:25 in Vasamed News
  • SVU 2014
    Written by
    Congratulations to SVU Committee and Subcommittee Chairs for putting on a great 2014 meeting! We will be back again next year! Left to right: Paulita LaPlante and Travis Stamper, Vasamed PAD-IQ Studycast. Left to right: Laurie Smith, CoreSound Studycast; Josh Kaplan, Zonare; Kevin Lugo and Kayla Devine, CoreSound Studycast.
    Written on Thursday, 14 August 2014 16:34 in Vasamed News

Upcoming Events